Trials / Completed
CompletedNCT04578483
Postoperative Pain Management of Therapeutic Surgery: a Prospective, Observational Cohort Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 634 (actual)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Poor management of post-operative acute pain can contribute to medical complications including pneumonia, deep vein thrombosis, infection and delayed healing, as well as the development of chronic. In contrast, appropriate pain control is capable of reducing the postoperative complications, preventing the development of chronic pain, and improving the quality of life. The workloads of medical staffs and health care cost are subsequently decreased. Recently, a lot of analgesic methods have been developed and used in clinical practice, such as patient-controlled analgesia, ultrasound-guided long-term analgesia and multimodal analgesia. This study is aimed to investigate the effect of dinalbuphine sebacate, a long-acting analgesic, in postoperative pain management. This real world data can serve as a reference toward high health care quality.
Detailed description
This is a prospective, observational, cohort study. Patients undergoing elective surgery will be invited to the study. The written informed consent will be obtained prior to participation. Demographic data, underlying condition, surgical procedures, consumption of anesthetics and analgesics, analgesic methods, postoperative complications, pain intensity and life quality will be collected from medical history and by questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ERDS group | After anesthesia, extended-release dinalbuphine sebacate (ERDS) is injected into gluteus maximus with ultrasound guidance. |
Timeline
- Start date
- 2020-10-27
- Primary completion
- 2022-09-30
- Completion
- 2022-12-31
- First posted
- 2020-10-08
- Last updated
- 2025-09-25
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04578483. Inclusion in this directory is not an endorsement.